Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems
Reexamination Certificate
2007-12-11
2007-12-11
Mullen, Kristen D. (Department: 3766)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Electrical therapeutic systems
Reexamination Certificate
active
10285803
ABSTRACT:
Thrombolytic and/or anticoagulation therapy of the present invention includes implantation of the discharge portion(s) of a catheter and, optionally, one or more electrodes on a lead, adjacent tissue(s) to be stimulated. Stimulation pulses, i.e., drug infusion pulses and optional electrical pulses, are supplied by a stimulator implanted remotely, and through the catheter or lead, which is tunneled subcutaneously between the stimulator and stimulation site. Stimulation sites include the coronary arteries, coronary veins, cerebral arteries, other blood vessels, chambers of the heart, mesenteric vessels, deep vessels of the leg, and other locations. Disclosed treatments include drugs used for chronic treatment and/or prevention of thromboembolic disease, for acute treatment of thromboembolic disease, for acute treatment of thrombosis, and combinations of these. The invention reduces or eliminates the incidence of thromboembolic disease and related morbidities, improve symptoms resulting from thromboembolic disease, and improve patient quality of life.
REFERENCES:
patent: 3598111 (1971-08-01), Kahn et al.
patent: 4000972 (1977-01-01), Braun et al.
patent: 4080966 (1978-03-01), McNally et al.
patent: 4232679 (1980-11-01), Schulman
patent: 4373527 (1983-02-01), Fischell
patent: 4408608 (1983-10-01), Daly et al.
patent: 4481950 (1984-11-01), Duggan
patent: 4608985 (1986-09-01), Crish et al.
patent: 4628942 (1986-12-01), Sweeney et al.
patent: 4649936 (1987-03-01), Ungar et al.
patent: 4793353 (1988-12-01), Borkan
patent: 4794934 (1989-01-01), Motoyama et al.
patent: 4922926 (1990-05-01), Hirschberg et al.
patent: 4998535 (1991-03-01), Selker et al.
patent: 5011472 (1991-04-01), Aebischer et al.
patent: 5078680 (1992-01-01), Samoff
patent: 5103821 (1992-04-01), King
patent: 5104859 (1992-04-01), Sollevi
patent: 5109850 (1992-05-01), Blanco et al.
patent: 5139028 (1992-08-01), Steinhaus et al.
patent: 5151268 (1992-09-01), Bang et al.
patent: 5193539 (1993-03-01), Schulman et al.
patent: 5193540 (1993-03-01), Schulman et al.
patent: 5199428 (1993-04-01), Obel et al.
patent: 5217022 (1993-06-01), Nathanielsz
patent: 5234404 (1993-08-01), Tuttle et al.
patent: 5246008 (1993-09-01), Mueller
patent: 5282840 (1994-02-01), Hudrlik
patent: 5305745 (1994-04-01), Zacouto
patent: 5312439 (1994-05-01), Loeb
patent: 5314458 (1994-05-01), Najafi et al.
patent: 5324316 (1994-06-01), Schulman et al.
patent: 5326706 (1994-07-01), Yland et al.
patent: 5338662 (1994-08-01), Sadri
patent: 5358514 (1994-10-01), Schulman et al.
patent: 5405367 (1995-04-01), Schulman et al.
patent: 5409009 (1995-04-01), Olson
patent: 5447529 (1995-09-01), Marchlinski et al.
patent: 5474552 (1995-12-01), Palti
patent: 5494822 (1996-02-01), Sadri
patent: 5513644 (1996-05-01), McClure et al.
patent: 5549650 (1996-08-01), Bornzin et al.
patent: 5551427 (1996-09-01), Altman
patent: 5562721 (1996-10-01), Marchlinski et al.
patent: 5634899 (1997-06-01), Shapland et al.
patent: 5697899 (1997-12-01), Hillman et al.
patent: 5716318 (1998-02-01), Manning
patent: 5716937 (1998-02-01), Haupert
patent: 5725563 (1998-03-01), Klotz
patent: 5753517 (1998-05-01), Brooks et al.
patent: 5755750 (1998-05-01), Petruska et al.
patent: 5759536 (1998-06-01), Bellgrau et al.
patent: 5824029 (1998-10-01), Weijand et al.
patent: 5840059 (1998-11-01), March et al.
patent: 5865787 (1999-02-01), Shapland et al.
patent: 5895416 (1999-04-01), Barreras et al.
patent: 5910484 (1999-06-01), Haupert et al.
patent: 5916154 (1999-06-01), Hobbs et al.
patent: 5995860 (1999-11-01), Sun et al.
patent: 6017318 (2000-01-01), Gauthier et al.
patent: 6051017 (2000-04-01), Loeb et al.
patent: 6058331 (2000-05-01), King
patent: 6073048 (2000-06-01), Kieval et al.
patent: 6112116 (2000-08-01), Fischell et al.
patent: 6122544 (2000-09-01), Organ
patent: 6154678 (2000-11-01), Lauro
patent: 6178349 (2001-01-01), Kieval
patent: 6183412 (2001-02-01), Benkowski et al.
patent: 6198965 (2001-03-01), Penner et al.
patent: 6205359 (2001-03-01), Boveja
patent: 6206914 (2001-03-01), Soykan et al.
patent: 6216045 (2001-04-01), Black et al.
patent: 6228844 (2001-05-01), Wolff et al.
patent: 6266564 (2001-07-01), Hill et al.
patent: 6341236 (2002-01-01), Osorio et al.
patent: 6347247 (2002-02-01), Dev et al.
patent: 6355243 (2002-03-01), Novokhatny et al.
patent: 6356777 (2002-03-01), Garfield et al.
patent: 6358247 (2002-03-01), Altman et al.
patent: 6447443 (2002-09-01), Keogh et al.
patent: 6464687 (2002-10-01), Ishikawa et al.
patent: 6526318 (2003-02-01), Ansarinia
patent: 6571127 (2003-05-01), Ben-Haim et al.
patent: 6650943 (2003-11-01), Whitehurst et al.
patent: 6712753 (2004-03-01), Manne
patent: 6845267 (2005-01-01), Harrison et al.
patent: 6907295 (2005-06-01), Gross et al.
patent: 6928320 (2005-08-01), King
patent: 6970741 (2005-11-01), Whitehurst et al.
patent: 2001/0003799 (2001-06-01), Boveja
patent: 2001/0044619 (2001-11-01), Altman
patent: 2002/0010492 (2002-01-01), Donovan et al.
patent: 2002/0016615 (2002-02-01), Dev et al.
patent: 2002/0022873 (2002-02-01), Erickson et al.
patent: 2003/0036773 (2003-02-01), Whitehurst et al.
patent: 2003/0236557 (2003-12-01), Whitehurst et al.
patent: 2003/0236558 (2003-12-01), Whitehurst et al.
patent: 2004/0015204 (2004-01-01), Whitehurst et al.
patent: 2004/0172089 (2004-09-01), Whitehurst et al.
patent: 2005/0101878 (2005-05-01), Daly et al.
patent: WO98/37926 (1998-09-01), None
patent: WO98/43700 (1998-10-01), None
patent: WO98/43701 (1998-10-01), None
patent: 01/26729 (2001-04-01), None
Atrial Fibrillation Investigators (AFI), “The Efficacy of Aspirin in Patients with Atrial Fibrillation. Analysis of Pooled Data From 3 Randomized Trials”, Arch Intern Med, vol. 157, (1997), pp. 1237-1240.
Atrial Fibrillation Investigators (AFI), “Bleeding During Antithrombotic Therapy in Patients with Atrial Fibrillation”, Arch Intern Med, vol. 156, (1996), pp. 409-416.
Atrial Fibrillation Investigators (AFI), “Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial Fibrillation. An Analysis of Pooled Data from Five Randomized Controlled Trials”, Arch Intern Med, vol. 154, (1994), pp. 1449-1457.
Blanchard, et al., “Immunoassays of Human Prothrombin Species which Correlate with Functional Coagulant Activities”, J Lab Clin Med, vol. 101, (1983), pp. 242-255.
Hassett, “Heparin Monitoring”, Transfusion Medicine Update, Feb. 1996, 3 pages.
Hirsh, “Heparin”, N Engl J Med, vol. 324, (1991), pp. 1565-1574.
Horton, et al., “Warfarin Therapy: Evolving Strategies in Anticoagulation”, American Family Physician, (Feb. 1, 1999), pp. 635-646.
Le, et al., “The International Normalized Ratio (INR) for Monitoring Warfarin Therapy: Reliability and Relation to Other Monitoring Methods”, Annals of Internal Medicine, vol. 120, (Apr. 1, 1994), pp. 552-558.
National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. “Tissue Plasminogen Activator for Acute Ischemic Stroke”, N Eng J Med, vol. 333, (1995), pp. 1581-1587.
Owen, et al.,The Diagnosis of Bleeding Disorders, Little Brown and Company, Boston, (1975), pp. 109-110.
Pepke-Zaba, et al., “Validation of Impedance Cardiography Measurements of Cardiac Output During Limited Exercise in Heart Transplant Recipients”, Transpl Int, vol. 3(2), (Jul. 1990), pp. 108-112.
Zivelin, et al., “Mechanism of the Anticoagulant Effect of Warfarin as Evaluated in Rabbits by Selective Depression of Individual Procoagulant Vitamin K-Dependent Clotting Factors”, J Clin Invest, vol. 92, (1993), pp. 2131-2140.
Asahara, et al., “Local Delivery of Vascular Endothelial Growth Factor Accelerates Re-Endothelialization and Attenuates Intimal Hyperplasia in Balloon-Injured Rat Carotid Artery”, Circulation, vol. 91, (1995), pp. 2793-2801.
Cameron, et al., “Micromodular Implants to Provide Electrical Stimulation of Paralyzed Muscles and Limbs”, IEEE Transactions on Biomedical Engineering, vol. 44, No. 9, (Sep. 1997), pp. 781
McClure Kelly H
Thacker James R
Whitehurst Todd K
Advanced Bionics Corporation
AdvantEdge Law Group, LLC
Laird Travis K.
Mullen Kristen D.
LandOfFree
Thrombolysis and chronic anticoagulation therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thrombolysis and chronic anticoagulation therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thrombolysis and chronic anticoagulation therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3894631